Committees

Commercialization Committee

Charter

The Commercialization Committee strives to:

  • Be the global communication hub between therapeutic societies, regulatory policy makers, institutional stem cell centres and industry for the advancement of clinical investigation in cell therapy and regenerative medicine.

Projects & Objectives

The Committee

Headshot of Anthony Ting

Chair

Anthony Ting, PhD

Bone Therapeutics
United States

Members

Sasha Aleksic, MSc
FUJIFILM Irvine Scientific
 United States

Julie Allickson, PhD
Wake Forest Institute of Regenerative Medicine
United States

Dolores Baksh, PhD
Cytiva
United States

Gerhard Bauer, PhD
UC Davis
United States

Caroline Blumer Toti
Miltenyi Biotec
Germany

Sarah Busch
Athersys
United States

Pat Carmody
Astellas
United States

Gil Carrasquinho
Santen SA
Switzerland

Lesley Chain
bluebird bio
United States

Bryan Choi, MD
SCRM
Incheon, South Korea

Dominic Clarke, PhD
HemaCare, A Charles River Company
United States

Matt Cuddihy
Takeda
United States

Lindsay Davies
NextCell Pharmaceuticals
Sweden

Lee Dunham
Catapult
United Kingdom

John Fink, MBA
Pall Corporation
United States

Mark Flowers
Cellares
United States

Miguel Forte, MD, PhD
Bone Therapeutics
Belgium

Haro Hartounian, PhD
New Jersey Innovation Institute
United States

Robert Jones
Cryoport
United Kingdom

Ankit Kansagra
UT South Western Medical Center
United States

Sven Kili
Antion Biosciences
United Kingdom

Lisa Kretzchmar
MilliporeSigma
United States

Antonio Lee, PhD

CARM
Seongnam, Korea

Bruce Levine, PhD
University of Pennsylvania
United States

David Lewandowski
BrooksLife Sciences
United States

Jim Lovgren
Berkeley Lights
United States

Josh Ludwig
ScaleReady
United States

Alex Lyness, PhD
West Pharmaceutical Services
United States

Aby Mathew, PhD
BioLife Solutions
United States

Michael May, PhD
CCRM
Canada

Bill Milligan
Steminent Biotherapeutics
Canada

Michitaka Nakao
FIRM
Japan

Erin Rasch
Be The Match BioTherapies
United States

Carson Rhodes, MBA
Terumo BCT
United States

Patrick Rivers, MBA
Aquilo Capital
United States

Alberto Santagastino
Lonza Biologics
Switzerland

Antonio Scatena
Gateway Analytical
United States

Nathan Smith
Cell Therapies Pty Ltd
Australia

Yoshie Tsurumaki
FIRM
Japan

Betty Woo
Thermo Fisher Scientific
United States

Xiaokui Zhang
Celularity
United States

Andrea Zobel, PhD
World Courier
Germany